Vol. 22 No. 1 (2021)

Original research

• A Budget Impact Analysis of the VENTANA PD-L1 SP142 Immunohistochemistry Assay Versus the Dako PD-L1 IHC 22C3 Assay in Patients With Advanced or Metastatic Triple-Negative Breast Cancer Treated With Atezolizumab in Combination With Nab-Paclitaxel

  Cristian Scatena, Roberto Ravasio, Paola Raimondo, Mario Giuliano

  • HTML
  • PDF

• Cost-Effectiveness Analysis of Alirocumab in High Cardiovascular-Risk Patients in Italy

  Massimiliano Povero, Lorenzo Pradelli, Andrea Serra, Francesca Fanelli, Luca Gazzi

  • HTML
  • PDF

• Osteoarthritis in Italy: Impact on Health-Related Quality of Life and Health Care Resources

  Patrizia Berto, Maria Domenica Sanna, James Jackson, Mia Berry, Jessica Jackson

  • HTML
  • PDF